Chinese Medical Journal (Jan 2023)

Benefit-risk assessment of incretin and other anti-diabetic agents in type 2 diabetes using a stochastic multicriteria acceptability analysis model

  • Sanbao Chai,
  • Shuqing Yu,
  • Fengqi Liu,
  • Zuoxiang Liu,
  • Qingqing Yang,
  • Feng Sun,
  • Jing Ni

DOI
https://doi.org/10.1097/CM9.0000000000002520
Journal volume & issue
Vol. 136, no. 1
pp. 102 – 104

Abstract

Read online

No abstracts available.